Identification of infectious species after resection of soft-tissue sarcomas

被引:7
|
作者
Ramsey, Duncan C. [1 ]
Jones, Ryan A. [2 ]
Weiss, Jason K. [2 ]
Hayden, Wyatt [1 ,2 ,3 ]
Hayden, James [1 ]
Barnes, Penelope [3 ]
Doung, Yee-Cheen [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Orthoped & Rehabil, 3181 SW Sam Jackson Pk Rd,Suite 2360, Portland, OR 97239 USA
[2] Univ Calif Davis, Dept Anesthesiol & Pain Med, Sacramento, CA 95817 USA
[3] PeaceHlth Med Grp, Dept Med, Bellingham, WA USA
关键词
anaerobic; bacteria; sarcoma; surgical oncology; wound infection; JOINT INFECTION; COMPLICATIONS; RADIOTHERAPY; BONE; PCR; DIAGNOSIS; BACTERIA; SAMPLES;
D O I
10.1002/jso.25434
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPathogenic species in deep tissue infections after soft-tissue sarcoma (STS) resection is largely unstudied, particularly the role of anaerobic bacteria, risks factors for those pathogens, and the time course of infection presentation. MethodsRetrospective analysis of 64 patients requiring operative debridement for deep tissue infection after STS resection was undertaken to identify infectious species and study risk factors for anaerobic infections. Kaplan-Meier methods examined the time course of infection presentation. ResultsSTS subtypes were most commonly pleomorphic STS, myxofibrosarcoma, and undifferentiated STS. Staphylococcus aureus was the most common organism isolated (56%). Twenty (31%) infections were positive for >= 1 anaerobic organism. Twelve gram-positive and 10 gram-negative aerobic organisms were isolated. Most (90%) anaerobic-containing infections were polymicrobial, vs 52% of purely aerobic infections. No significant risk factors for anaerobic infections were identified. Median time from tumor resection until debridement was significantly greater for anaerobic infections (54.5 days) than for purely aerobic infections (29.5 days; P=0.004), a difference so pronounced that using presentation after 53 days as a proxy for the presence of anaerobic pathogens had an accuracy of 81%. ConclusionsBecause polymicrobial and anaerobic bacterial infections are common, we strongly support antibiotic use with anaerobic coverage at debridement, particularly for infections presenting later.
引用
收藏
页码:836 / 842
页数:7
相关论文
共 50 条
  • [21] Surgical Management of Retroperitoneal Soft-Tissue Sarcomas - An Overview
    Garlipp, B.
    Schulz, H. -U.
    Zeile, M.
    Lippert, H.
    Meyer, F.
    ZENTRALBLATT FUR CHIRURGIE, 2010, 135 (06): : 564 - 574
  • [22] TREATMENT OF EXTREMITY SOFT-TISSUE SARCOMAS WITH SURGERY AND RADIOTHERAPY
    ROBINSON, M
    BARR, L
    FISHER, C
    FRYATT, I
    STOTTER, A
    HARMER, C
    WILTSHAW, E
    WESTBURY, G
    RADIOTHERAPY AND ONCOLOGY, 1990, 18 (03) : 221 - 233
  • [23] PRETREATMENT OXYGENATION PROFILES OF HUMAN SOFT-TISSUE SARCOMAS
    BRIZEL, DM
    ROSNER, GL
    HARRELSON, J
    PROSNITZ, LR
    DEWHIRST, MW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (03): : 635 - 642
  • [24] The use of the anterolateral thigh flap for microsurgical reconstruction of distal extremities after oncosurgical resection of soft-tissue sarcomas
    Momeni, Arash
    Kalash, Ziad
    Stark, G. Bjoern
    Bannasch, Holger
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2011, 64 (05) : 643 - 648
  • [25] Soft-Tissue sarcomas: Diagnosis and treatment from the plastic reconstructive surgeon perspective
    Kapukaya, Rana
    TURKISH JOURNAL OF PLASTIC SURGERY, 2022, 30 (04) : 115 - 120
  • [26] RADIOTHERAPEUTIC STRATEGIES FOR SOFT-TISSUE SARCOMAS IN ADULTS
    BUDACH, V
    DINGES, S
    BUDACH, W
    RADIOLOGE, 1992, 32 (12): : 606 - 614
  • [27] Prognostic factors of retroperitoneal soft-tissue sarcomas
    Derici, Hayrullah
    Tansug, Tugrul
    Nazli, Okay
    Bozdag, Ali Dogan
    Reyhan, Enver
    Kara, Cemal
    CHIRURGISCHE GASTROENTEROLOGIE, 2006, 22 (03): : 179 - 184
  • [28] SPECIAL PROBLEMS OF GASTROINTESTINAL SOFT-TISSUE SARCOMAS
    LEHNERT, T
    CHIRURG, 1993, 64 (07): : 535 - 543
  • [29] Facts and Hopes in Immunotherapy of Soft-Tissue Sarcomas
    Martin-Broto, Javier
    Moura, David S.
    Van Tine, Brian A.
    CLINICAL CANCER RESEARCH, 2020, 26 (22) : 5801 - 5808
  • [30] Newer therapeutic strategies for soft-tissue sarcomas
    Bourcier, Kevin
    Italiano, Antoine
    PHARMACOLOGY & THERAPEUTICS, 2018, 188 : 118 - 123